[go: up one dir, main page]

CY1114363T1 - Ανθελμινθικος συνδυασμος - Google Patents

Ανθελμινθικος συνδυασμος

Info

Publication number
CY1114363T1
CY1114363T1 CY20131100683T CY131100683T CY1114363T1 CY 1114363 T1 CY1114363 T1 CY 1114363T1 CY 20131100683 T CY20131100683 T CY 20131100683T CY 131100683 T CY131100683 T CY 131100683T CY 1114363 T1 CY1114363 T1 CY 1114363T1
Authority
CY
Cyprus
Prior art keywords
deoxoparaquamide
anthelmintic
anthelmintic combination
combination
avamectin
Prior art date
Application number
CY20131100683T
Other languages
English (en)
Inventor
Timothy G Geary
Peter Rolfe
Original Assignee
Zoetis Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Llc filed Critical Zoetis Llc
Publication of CY1114363T1 publication Critical patent/CY1114363T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Παρέχεται μία μέθοδος για τη θεραπεία παρασιτικών μολύνσεων σε θηλαστικά, που περιλαμβάνει το στάδιο της ταυτόχρονης ή διαδοχικής χορήγησης στο θηλαστικό αποτελεσματικών ποσοτήτων (α) 2-δεσοξοπαραερκουαμιδίου, και (Β) αβαμηκτίνης. Επίσης παρέχεται μία ανθελμινθική σύνθεση που περιέχει 2-δεσοξοπαραερκουαμίδιο και αβαμηκτίνη.
CY20131100683T 2007-06-29 2013-08-09 Ανθελμινθικος συνδυασμος CY1114363T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94701507P 2007-06-29 2007-06-29
EP08762949.9A EP2170321B1 (en) 2007-06-29 2008-06-16 Anthelmintic combination

Publications (1)

Publication Number Publication Date
CY1114363T1 true CY1114363T1 (el) 2016-08-31

Family

ID=39831661

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100683T CY1114363T1 (el) 2007-06-29 2013-08-09 Ανθελμινθικος συνδυασμος

Country Status (17)

Country Link
US (1) US8440633B2 (el)
EP (1) EP2170321B1 (el)
JP (1) JP5462456B2 (el)
CN (1) CN101686962B (el)
AR (1) AR067347A1 (el)
AU (1) AU2008272646B2 (el)
BR (1) BRPI0813235B1 (el)
CA (1) CA2690111C (el)
CY (1) CY1114363T1 (el)
DK (1) DK2170321T3 (el)
ES (1) ES2423505T3 (el)
NZ (1) NZ581859A (el)
PL (1) PL2170321T3 (el)
PT (1) PT2170321E (el)
TW (1) TWI352592B (el)
WO (1) WO2009004432A1 (el)
ZA (1) ZA201000672B (el)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009313920B2 (en) 2008-11-14 2014-10-23 Boehringer Ingelheim Animal Health USA Inc. Enantiomerically enriched aryloazol- 2 -yl cyanoethylamino paraciticidal compounds
NZ612417A (en) 2008-11-19 2015-02-27 Merial Inc Compositions comprising an aryl pyrazole and/or a formamidine, methods and uses thereof
AU2009322206B2 (en) 2008-12-04 2015-03-05 Boehringer Ingelheim Animal Health USA Inc. Dimeric avermectin and milbemycin derivatives
CA2782902C (en) 2009-12-04 2017-10-17 Merial Limited Pesticidal bis-organosulfur compounds
NZ600845A (en) 2009-12-17 2014-08-29 Merial Ltd Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles
MX384937B (es) 2009-12-17 2025-03-14 Merial Ltd Compuestos de dihidroazol antiparasiticos y composiciones que comprenden los mismos.
UA108641C2 (uk) 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
AU2011328948B2 (en) 2010-11-16 2016-08-04 Centre National De La Recherche Scientifique (Cnrs) Novel monensin derivatives for the treatment and prevention of protozoal infections
WO2013003168A1 (en) 2011-06-27 2013-01-03 Merial Limited Novel insect-repellent coumarin derivatives, syntheses, and methods of use
ES2618813T3 (es) 2011-06-27 2017-06-22 Merial, Inc. Compuestos y composiciones de éter amido-piridílico y uso contra los parásitos
ES2834427T3 (es) 2011-09-12 2021-06-17 Boehringer Ingelheim Animal Health Usa Inc Composiciones parasiticidas que comprenden un agente activo de isoxazolina, procedimientos y usos de las mismas
US20130079394A1 (en) 2011-09-23 2013-03-28 Cnrs (Centre National Recherche Scientifique) Indirect modeling of new repellent molecules active against insects, acarids, and other arthropods
KR102066757B1 (ko) 2011-11-17 2020-01-15 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 아릴 피라졸 및 치환된 이미다졸을 함유하는 조성물, 그의 방법 및 용도
PT3351546T (pt) 2011-12-02 2024-03-07 Boehringer Ingelheim Vetmedica Gmbh Formulações injectáveis de moxidectina com ação prolongada
PE20141907A1 (es) 2012-02-06 2014-12-13 Merial Ltd Composiciones veterinarias orales parasiticidas que comprenden agentes activos de accion sistemica, metodos y usos de las mismas
JO3626B1 (ar) 2012-02-23 2020-08-27 Merial Inc تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها
MX345971B (es) 2012-04-20 2017-02-28 Merial Ltd Composiciones parasiticidas que comprenden derivados de benzimidazol, metodos y usos de los mismos.
HRP20181448T1 (hr) 2012-11-20 2018-11-02 Merial, Inc. Antihelmintski spojevi i sastavi te postupak za njihovu uporabu
AP2016009184A0 (en) 2013-11-01 2016-04-30 Merial Ltd Antiparisitic and pesticidal isoxazoline compounds
US10857121B2 (en) 2014-04-17 2020-12-08 Merial Inc. Use of malononitrile compounds for protecting animals from parasites
MX375153B (es) 2014-05-19 2025-03-06 Boehringer Ingelheim Animal Health Usa Inc Compuestos antihelminticos.
EP3517524B1 (en) 2014-06-19 2021-05-26 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising indole derivatives, methods and uses thereof
EP3211998B1 (en) 2014-10-31 2021-04-07 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal composition comprising fipronil
UY36570A (es) 2015-02-26 2016-10-31 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
SMT202100417T1 (it) 2015-05-20 2021-09-14 Boehringer Ingelheim Animal Health Usa Inc Composti depsipeptidici antielmintici
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
US10653144B2 (en) 2016-10-14 2020-05-19 Boehringer Ingelheim Animal Health USA Inc. Pesticidal and parasiticidal vinyl isoxazoline compounds
CN110167921A (zh) 2016-11-16 2019-08-23 勃林格殷格翰动物保健美国公司 驱蠕虫缩肽化合物
AU2018318945A1 (en) 2017-08-14 2020-03-05 Boehringer Ingelheim Animal Health USA Inc. Pesticidal and parasiticidal pyrazole-isoxazoline compounds
US11583545B2 (en) 2018-02-08 2023-02-21 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof
WO2020014068A1 (en) 2018-07-09 2020-01-16 Boehringer Ingelheim Animal Health USA Inc. Anthelminthic heterocyclic compounds
AR116524A1 (es) * 2018-10-04 2021-05-19 Elanco Tiergesundheit Ag Potenciación de tratamiento de helmintos
CN113260419A (zh) 2018-11-20 2021-08-13 勃林格殷格翰动物保健美国公司 吲唑基氰基乙基氨基化合物、其组合物、其制备方法和其使用方法
CA3129329A1 (en) 2019-03-01 2020-09-10 Boehringer Ingelheim Animal Health USA Inc. Injectable clorsulon compositions, methods and uses thereof
WO2020191091A1 (en) 2019-03-19 2020-09-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic aza-benzothiophene and aza-benzofuran compounds
IL298596A (en) 2020-05-29 2023-01-01 Boehringer Ingelheim Animal Health Usa Inc Anthelmintic heterocyclic compounds
WO2022140728A1 (en) 2020-12-21 2022-06-30 Boehringer Ingelheim Animam Health Usa Inc. Parasiticidal collar comprising isoxazoline compounds
JP2025507585A (ja) 2022-02-17 2025-03-21 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー 流体製品メーラーを提供する方法及びシステム

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207655A (en) * 1983-04-07 1986-09-10 Merck & Co Inc Synergistic veterinary compositions containing an avermectin compound and clorsulon
GB2221621A (en) * 1988-08-12 1990-02-14 Merck & Co Inc Synergistic antiparasitic combinations of avermectin and pyrantel
PE20011289A1 (es) 2000-04-07 2001-12-21 Upjohn Co Composiciones antihelminticas que comprenden lactonas macrociclicas y espirodioxepinoindoles
AU2003900505A0 (en) * 2003-02-05 2003-02-20 Jurox Pty Ltd Anthelmintic composition

Also Published As

Publication number Publication date
JP5462456B2 (ja) 2014-04-02
AU2008272646B2 (en) 2013-08-22
DK2170321T3 (da) 2013-07-29
WO2009004432A1 (en) 2009-01-08
NZ581859A (en) 2012-06-29
AU2008272646A1 (en) 2009-01-08
JP2009051820A (ja) 2009-03-12
US8440633B2 (en) 2013-05-14
TWI352592B (en) 2011-11-21
TW200918044A (en) 2009-05-01
EP2170321B1 (en) 2013-05-22
BRPI0813235B1 (pt) 2019-01-22
AR067347A1 (es) 2009-10-07
PT2170321E (pt) 2013-08-01
PL2170321T3 (pl) 2013-12-31
ES2423505T3 (es) 2013-09-20
US20100197624A1 (en) 2010-08-05
CA2690111A1 (en) 2009-01-08
EP2170321A1 (en) 2010-04-07
CN101686962A (zh) 2010-03-31
CA2690111C (en) 2011-11-15
BRPI0813235A2 (pt) 2014-12-23
CN101686962B (zh) 2012-05-23
ZA201000672B (en) 2010-10-27

Similar Documents

Publication Publication Date Title
CY1114363T1 (el) Ανθελμινθικος συνδυασμος
CY1122812T1 (el) Δοσολογικο σχημα για εναν αγωνιστη του υποδοχεα s1p
CO6511251A2 (es) Compuestos quimicos
CY1121125T1 (el) Συνθεσεις για τη θεραπευτικη αντιμετωπιση του πονου και/ή της φλεγμονης
CL2008003406A1 (es) Compuestos derivados de quinolina; composicion farmaceutica que los comprende; y uso en el tratamiento de una infeccion por vih.
CR10277A (es) Pirazolquinolonas como potentes inhibidores de parp
CY1118017T1 (el) Υποβαλλοντας σε αγωγη την ανεπαρκεια και το ελλειμμα βιταμινης d με 25-υδροξυβιταμινη d2 και 25-υδροξυβιταμινη d3
CO6480977A2 (es) Agonistas de gpr119
CY1115751T1 (el) Φαρμακευτικος συνδυασμος 3-(3-διμεθυλαμινο-1-αιθυλ-2-μεθυλπροπυλ)-φαινολης και ενος αντιεπιληπτικου
CY1110989T1 (el) Χρηση 3-(4-αμινο-1-οξο-1,3-διυδρο-ισοϊνδολ-2-υλο)-πιπεριδινο-2,6-διονης για την αντιμετωπιση λεμφωματων κυτταρων του μανδυα
CR11626A (es) Inhibidores de beta-lactamasa
ECSP077182A (es) Metodos para el tratamiento de infecciones endobronquiales
CL2011000835A1 (es) Compuestos derivados de espiro-oxindol; moduladores de los canales de sodio; composicion farmaceutica que comprende a dicho compuesto; y uso en el tratamiento del dolor, depresion, enfermedades cardiovasculares, respiratorias, psiquiatricas, entre otras.
CL2008002228A1 (es) Compuestos derivados de imidazopiridinonas, agonista de tlr7; procedimiento de preparacion; compuestos intermediarios; composiicon farmaceutica que los comprende; y uso en infecciones virales, bacterianas y fungicas.
ECSP099634A (es) Derivados de piridazinona útiles como inhibidores de glucano sintasa
MD20140093A2 (ro) Compoziţii masticabile de uz veterinar care conţin agent activ izoxazolinic şi utilizarea acestora în tratamentul sau prevenirea unei infestări sau infecţii parazitare
ECSP10010413A (es) Inhibidores macrociclicos de serina proteasa
DOP2006000268A (es) Agentes antibacterianos
UY31860A (es) Piridinas de tiazolo como inhibidoras de la adn girasa
UY30158A1 (es) Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor
MX2023002233A (es) Compuestos fosfolipidos y usos de estos.
BR112017004153A2 (pt) métodos para tratamento de infecções por protozoários
CL2008000202A1 (es) Compuestos derivados de n-aril-acetamida, antagonista trpv1;composicion farmaceutica que los comprende, utiles en el tratamiento del dolor.
CR20240363A (es) Compuestos y métodos para el tratamiento de infecciones virales.
CY1116831T1 (el) ΧΡΗΣΗ 24-norUDCA